Mimedx (MDXG) Liabilities from Discontinued Operations (2022 - 2024)
Mimedx (MDXG) reported Liabilities from Discontinued Operations of 217000.0 for Q2 2024, down 36.92% sequentially from 344000.0 in Q1 2024.
Mimedx (MDXG) Liabilities from Discontinued Operations (2022 - 2024) Analysis & Trends
Mimedx (MDXG) has 3 years of Liabilities from Discontinued Operations data on file, last reported at 217000.0 in Q2 2024.
- For the quarter ending Q2 2024, Liabilities from Discontinued Operations changed N/A year-over-year to 217000.0; the trailing twelve-month figure through Jun 2024 stood at 217000.0 (changed N/A YoY), and the FY2023 full-year result was 1352000.0, down 8.59% from the prior year.
- Liabilities from Discontinued Operations fell to 217000.0 in Q2 2024, from 344000.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 1479000.0 in Q4 2022 to a low of 217000.0 in Q2 2024.
- A 3-year average of 848000.0 and a median of 848000.0 in 2023 frame the typical range for Liabilities from Discontinued Operations.
- Peak annual rise in Liabilities from Discontinued Operations reached 8.59% in 2023, while the deepest fall reached 8.59% in 2023.
- Tracing MDXG's Liabilities from Discontinued Operations over 3 years: stood at 1479000.0 in 2022, then fell by 8.59% to 1352000.0 in 2023, then tumbled by 83.95% to 217000.0 in 2024.
- Business Quant data shows MDXG's Liabilities from Discontinued Operations at 217000.0 in Q2 2024, 344000.0 in Q1 2024, and 1352000.0 in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mimedx | 615.09 Mn | 455.31 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 217,000.00 |
| Jun 30, 2024 | 217,000.00 |
| Mar 31, 2024 | 344,000.00 |
| Mar 31, 2024 | 344,000.00 |
| Dec 31, 2023 | 1.35 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Dec 31, 2022 | 1.48 Mn |
| Dec 31, 2022 | 1.48 Mn |